1
|
Horvat-Menih I, Khan AS, McLean MA, Duarte J, Serrao E, Ursprung S, Kaggie JD, Gill AB, Priest AN, Crispin-Ortuzar M, Warren AY, Welsh SJ, Mitchell TJ, Stewart GD, Gallagher FA. K-Means Clustering of Hyperpolarised 13C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest Grade. Cancers (Basel) 2025; 17:569. [PMID: 40002163 PMCID: PMC11852806 DOI: 10.3390/cancers17040569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2024] [Revised: 01/19/2025] [Accepted: 01/24/2025] [Indexed: 02/27/2025] Open
Abstract
Background: Early and accurate grading of renal cell carcinoma (RCC) improves patient risk stratification and has implications for clinical management and mortality. However, current diagnostic approaches using imaging and renal mass biopsy have limited specificity and may lead to undergrading. Methods: This study explored the use of hyperpolarised [1-13C]pyruvate MRI (HP 13C-MRI) to identify the most aggressive areas within the tumour of patients with clear cell renal cell carcinoma (ccRCC) as a method to guide biopsy targeting and to reduce undergrading. Six patients with ccRCC underwent presurgical HP 13C-MRI and conventional contrast-enhanced MRI. From the imaging data, three k-means clusters were computed by combining the kPL as a marker of metabolic activity, and the 13C-pyruvate signal-to-noise ratio (SNRPyr) as a perfusion surrogate. The combined clusters were compared to those derived from individual parameters and to those derived from the percentage of enhancement on the nephrographic phase (%NG). The diagnostic performance of each cluster was assessed based on its ability to predict the highest histological tumour grade in postsurgical tissue samples. The postsurgical tissue samples underwent immunohistochemical staining for the pyruvate transporter (monocarboxylate transporter 1, MCT1), as well as RNA and whole-exome sequencing. Results: The clustering approach combining SNRPyr and kPL demonstrated the best performance for predicting the highest tumour grade: specificity 85%; sensitivity 64%; positive predictive value 82%; and negative predictive value 68%. Epithelial MCT1 was identified as the major determinant of the HP 13C-MRI signal. The perfusion/metabolism mismatch cluster showed an increased expression of metabolic genes and markers of aggressiveness. Conclusions: This study demonstrates the potential of using HP 13C-MRI-derived metabolic clusters to identify intratumoral variations in tumour grade with high specificity. This work supports the use of metabolic imaging to guide biopsies to the most aggressive tumour regions and could potentially reduce sampling error.
Collapse
Affiliation(s)
- Ines Horvat-Menih
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Alixander S. Khan
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Mary A. McLean
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Joao Duarte
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Eva Serrao
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Stephan Ursprung
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Joshua D. Kaggie
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| | - Andrew B. Gill
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
- Department of Radiology, Royal Papworth Hospitals NHS Foundation Trust, Cambridge CB2 0AY, UK
| | - Andrew N. Priest
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
- Department of Radiology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
| | | | - Anne Y. Warren
- Department of Pathology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK;
| | - Sarah J. Welsh
- Pinto Medical Consultancy, Cart House 2 Copley Hill Business Park, Cambridge CB22 3GN, UK;
| | - Thomas J. Mitchell
- Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK; (T.J.M.); (G.D.S.)
| | - Grant D. Stewart
- Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK; (T.J.M.); (G.D.S.)
| | - Ferdia A. Gallagher
- Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK; (I.H.-M.); (A.S.K.); (M.A.M.); (J.D.); (E.S.); (S.U.); (J.D.K.); (A.B.G.); (A.N.P.)
| |
Collapse
|
2
|
Wang X, Wang Y, Qi C, Qiao S, Yang S, Wang R, Jin H, Zhang J. The Application of Morphogo in the Detection of Megakaryocytes from Bone Marrow Digital Images with Convolutional Neural Networks. Technol Cancer Res Treat 2023; 22:15330338221150069. [PMID: 36700246 PMCID: PMC9896096 DOI: 10.1177/15330338221150069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The evaluation of megakaryocytes is an important part of the work up on bone marrow smear examination. It has significance in the differential diagnosis, therapeutic efficacy assessment, and predication of prognosis of many hematologic diseases. The process of manual identification of megakaryocytes are tedious and lack of reproducibility; therefore, a reliable method of automated megakaryocytic identification is urgently needed. Three hundred and thirty-three bone marrow aspirate smears were digitized by Morphogo system. Pathologists annotated megakaryocytes on the digital images of marrow smears are applied to construct a large dataset for testing the system's predictive performance. Subsequently, we obtained megakaryocyte count and classification for each sample by different methods (system-automated analysis, system-assisted analysis, and microscopic examination) to study the correlation between different counting and classification methods. Morphogo system localized cells likely to be megakaryocytes on digital smears, which were later annotated by pathologists and the system, respectively. The system showed outstanding performance in identifying megakaryocytes in bone marrow smears with high sensitivity (96.57%) and specificity (89.71%). The overall correlation between the different methods was confirmed the high consistency (r ≥ 0.7218, R2 ≥ 0.5211) with microscopic examination in classifying megakaryocytes. Morphogo system was proved as a reliable screen tool for analyzing megakaryocytes. The application of Morphogo system shows promises to advance the automation and standardization of bone marrow smear examination.
Collapse
Affiliation(s)
- Xiaofen Wang
- Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang, China,Key Laboratory of Precision Medicine in Diagnosis and Monitoring
Research of Zhejiang Province, China
| | - Ying Wang
- Department of Medical Development, Hangzhou Zhiwei
Information&Technology Ltd., Hangzhou, China
| | - Chao Qi
- Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang, China,Key Laboratory of Precision Medicine in Diagnosis and Monitoring
Research of Zhejiang Province, China
| | - Sai Qiao
- Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang, China,Key Laboratory of Precision Medicine in Diagnosis and Monitoring
Research of Zhejiang Province, China
| | - Suwen Yang
- Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang, China,Key Laboratory of Precision Medicine in Diagnosis and Monitoring
Research of Zhejiang Province, China
| | - Rongrong Wang
- Department of Clinical Pharmacy, the First Affiliated Hospital,
Zhejiang University, Hangzhou, Zhejiang, China
| | - Hong Jin
- Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang, China,Key Laboratory of Precision Medicine in Diagnosis and Monitoring
Research of Zhejiang Province, China
| | - Jun Zhang
- Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang, China,Key Laboratory of Precision Medicine in Diagnosis and Monitoring
Research of Zhejiang Province, China,Jun Zhang, Clinical Laboratory, Sir Run Run
Shaw Hospital, School of Medicine, Zhejiang University, No.3, Qingchun East
Road, Shangcheng District, Hangzhou, Zhejiang 310016, China.
Hong Jin, Clinical Laboratory, Sir
Run Run Shaw Hospital, School of Medicine, Zhejiang University, No.3, Qingchun
East Road, Shangcheng District, Hangzhou, Zhejiang 310016, China.
| |
Collapse
|
3
|
Dwivedi DK, Xi Y, Kapur P, Madhuranthakam AJ, Lewis MA, Udayakumar D, Rasmussen R, Yuan Q, Bagrodia A, Margulis V, Fulkerson M, Brugarolas J, Cadeddu JA, Pedrosa I. Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience. Clin Genitourin Cancer 2021; 19:12-21.e1. [PMID: 32669212 PMCID: PMC7680717 DOI: 10.1016/j.clgc.2020.05.011] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Revised: 05/16/2020] [Accepted: 05/16/2020] [Indexed: 12/13/2022]
Abstract
INTRODUCTION Percutaneous renal mass biopsy results can accurately diagnose clear cell renal cell carcinoma (ccRCC); however, their reliability to determine nuclear grade in larger, heterogeneous tumors is limited. We assessed the ability of radiomics analyses of magnetic resonance imaging (MRI) to predict high-grade (HG) histology in ccRCC. PATIENTS AND METHODS Seventy patients with a renal mass underwent 3 T MRI before surgery between August 2012 and August 2017. Tumor length, first-order statistics, and Haralick texture features were calculated on T2-weighted and dynamic contrast-enhanced (DCE) MRI after manual tumor segmentation. After a variable clustering algorithm was applied, tumor length, washout, and all cluster features were evaluated univariably by receiver operating characteristic curves. Three logistic regression models were constructed to assess the predictability of HG ccRCC and then cross-validated. RESULTS At univariate analysis, area under the curve values of length, and DCE texture cluster 1 and cluster 3 for diagnosis of HG ccRCC were 0.7 (95% confidence interval [CI], 0.58-0.82, false discovery rate P = .008), 0.72 (95% CI, 0.59-0.84, false discovery rate P = .004), and 0.75 (95% CI, 0.63-0.87, false discovery rate P = .0009), respectively. At multivariable analysis, area under the curve for model 1 (tumor length only), model 2 (length + DCE clusters 3 and 4), and model 3 (DCE cluster 1 and 3) for diagnosis of HG ccRCC were 0.67 (95% CI, 0.54-0.79), 0.82 (95% CI, 0.71-0.92), and 0.81 (95% CI, 0.70-0.91), respectively. CONCLUSION Radiomics analysis of MRI images was superior to tumor size for the prediction of HG histology in ccRCC in our cohort.
Collapse
Affiliation(s)
| | - Yin Xi
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX; Department of Clinical Science, UT Southwestern Medical Center, Dallas, TX
| | - Payal Kapur
- Department of Pathology, UT Southwestern Medical Center, Dallas, TX; Department of Urology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX
| | - Ananth J Madhuranthakam
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX; Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX
| | - Matthew A Lewis
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX
| | - Durga Udayakumar
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX; Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX
| | - Robert Rasmussen
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX
| | - Qing Yuan
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX
| | - Aditya Bagrodia
- Department of Urology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX
| | - Vitaly Margulis
- Department of Urology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX
| | | | - James Brugarolas
- Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
| | - Jeffrey A Cadeddu
- Department of Urology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX
| | - Ivan Pedrosa
- Department of Radiology, UT Southwestern Medical Center, Dallas, TX; Department of Urology, UT Southwestern Medical Center, Dallas, TX; Kidney Cancer Program, UT Southwestern Medical Center, Dallas, TX; Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX.
| |
Collapse
|
4
|
Heller MT, Furlan A, Kawashima A. Multiparametric MR for Solid Renal Mass Characterization. Magn Reson Imaging Clin N Am 2020; 28:457-469. [PMID: 32624162 DOI: 10.1016/j.mric.2020.03.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Multiparametric MR provides a noninvasive means for improved differentiation between benign and malignant solid renal masses. Although most large, heterogeneous renal masses are due to renal cell carcinoma, smaller "indeterminate" renal masses are being identified on cross-sectional imaging. Although definitive diagnosis of a solid renal mass may not always be possible by MR imaging, integrated evaluation of multiple MR imaging parameters can result in concise differential diagnosis. Multiparametric MR should be considered a critical step in the triage of patients with a solid renal mass for whom treatment options are being considered in the context of morbidity, prognosis, and mortality.
Collapse
Affiliation(s)
- Matthew T Heller
- Department of Radiology, Mayo Clinic, Mayo Clinic Hospital, 5777 East Mayo Boulevard, PX SS 01 RADLGY, Phoenix, AZ 85054, USA.
| | - Alessandro Furlan
- Department of Radiology, University of Pittsburgh, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA
| | - Akira Kawashima
- Department of Radiology, Mayo Clinic, Mayo Clinic Hospital, 5777 East Mayo Boulevard, PX SS 01 RADLGY, Phoenix, AZ 85054, USA
| |
Collapse
|
5
|
Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings. Eur Radiol 2019; 29:5832-5843. [PMID: 30887194 DOI: 10.1007/s00330-019-06087-x] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Revised: 01/23/2019] [Accepted: 02/08/2019] [Indexed: 12/28/2022]
Abstract
OBJECTIVES To assess the potential of T1 mapping-based extracellular volume fraction (ECV) for the identification of higher grade clear cell renal cell carcinoma (cRCC), based on histopathology as the reference standard. METHODS For this single-center, institutional review board-approved prospective study, 27 patients (17 men, median age 62 ± 12.4 years) with pathologic diagnosis of cRCC (nucleolar International Society of Urological Pathology (ISUP) grading) received abdominal MRI scans at 1.5 T using a modified Look-Locker inversion recovery (MOLLI) sequence between January 2017 and June 2018. Quantitative T1 values were measured at different time points (pre- and postcontrast agent administration) and quantification of the ECV was performed on MRI and histological sections (H&E staining). RESULTS Reduction in T1 value after contrast agent administration and MR-derived ECV were reliable predictors for differentiating higher from lower grade cRCC. Postcontrast T1diff values (T1diff = T1 difference between the native and nephrogenic phase) and MR-derived ECV were significantly higher for higher grade cRCC (ISUP grades 3-4) compared with lower grade cRCC (ISUP grades 1-2) (p < 0.001). A cutoff value of 700 ms could distinguish higher grade from lower grade tumors with 100% (95% CI 0.69-1.00) sensitivity and 82% (95% CI 0.57-0.96) specificity. There was a positive and strong correlation between MR-derived ECV and histological ECV (p < 0.01, r = 0.88). Interobserver agreement for quantitative longitudinal relaxation times in the T1 maps was excellent. CONCLUSIONS T1 mapping with ECV measurement could represent a novel in vivo biomarker for the classification of cRCC regarding their nucleolar grade, providing incremental diagnostic value as a quantitative MR marker. KEY POINTS • Reduction in MRI T1 relaxation times after contrast agent administration and MR-derived extracellular volume fraction are useful parameters for grading of clear cell renal cell carcinoma (cRCC). • T1 differences between the native and the nephrogenic phase are higher for higher grade cRCC compared with lower grade cRCC and MRI-derived extracellular volume fraction (ECV) and histological ECV show a strong correlation. • T1 mapping with ECV measurement may be helpful for the noninvasive assessment of cRCC pathology, being a safe and feasible method, and it has potential to optimize individualized treatment options, e.g., in the decision of active surveillance.
Collapse
|
6
|
Xu X, Li N, Chen Y, Ouyang H, Zhao X, Zhou J. Diagnostic efficacy of MRI for pre-operative assessment of ovarian malignancy in endometrial carcinoma: A decision tree analysis. Magn Reson Imaging 2018; 57:285-292. [PMID: 30580078 DOI: 10.1016/j.mri.2018.12.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Revised: 10/17/2018] [Accepted: 12/19/2018] [Indexed: 11/24/2022]
Abstract
AIM Accurate preoperative assessment of ovarian malignancy in endometrial carcinoma helps in determining the decision to preserve the ovaries in individualized treatment. This study adopted decision tree method to evaluate the diagnostic efficiency of pelvic MRI and clinical data of patients for preoperative identification of endometrial carcinoma-combined ovarian malignancy (EC-OM). MATERIAL AND METHODS This retrospective study included a total of 801 patients, and postoperative pathological examinations identified 58 EC-OM group and 743 endometrial carcinoma cases without ovarian malignancy (EC group). Diagnostic efficiency of pelvic MRI in EC-OM was calculated by comparing the clinical data and imaging features of patients in the two groups. Decision tree analysis was performed to screen out associative indexes and establish a diagnostic model for EC-OM. RESULTS Pelvic MRI showed that, EC-OM group showed deeper invasion into the myometrium, and higher percentages of patients with cervical or cornual involvement, or metastasis of lymph nodes or peritoneum than EC group (P = 0.00). Preoperative pelvic MRI showed a sensitivity of 51.72% and a specificity of 99.87% when detecting ovarian malignancy in endometrial carcinoma. Decision tree model obtained a sensitivity of 89.66%, with an AUC (area under ROC curve) of 0.949 (95% CI 0.906, 0.993, P < 0.001). CONCLUSION Decision tree analysis based on pelvic MRI and clinical data of patients showed that the detection rate of ovarian malignancy could be increased for patients with endometrial carcinoma.
Collapse
Affiliation(s)
- Xiaojuan Xu
- Department of Diagnostic Imaging, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Nan Li
- Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China
| | - Yan Chen
- Department of Diagnostic Imaging, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Han Ouyang
- Department of Diagnostic Imaging, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Xinming Zhao
- Department of Diagnostic Imaging, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Jing Zhou
- Department of Gynecology, The Central Hospital of Karamay, Xinjiang, Uyghur Autonomous Region, China.
| |
Collapse
|
7
|
Zhou JY, Wang YC, Zeng CH, Ju SH. Renal Functional MRI and Its Application. J Magn Reson Imaging 2018; 48:863-881. [PMID: 30102436 DOI: 10.1002/jmri.26180] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Accepted: 04/10/2018] [Indexed: 12/11/2022] Open
Abstract
Renal function varies according to the nature and stage of diseases. Renal functional magnetic resonance imaging (fMRI), a technique considered superior to the most common method used to estimate the glomerular filtration rate, allows for noninvasive, accurate measurements of renal structures and functions in both animals and humans. It has become increasingly prevalent in research and clinical applications. In recent years, renal fMRI has developed rapidly with progress in MRI hardware and emerging postprocessing algorithms. Function-related imaging markers can be acquired via renal fMRI, encompassing water molecular diffusion, perfusion, and oxygenation. This review focuses on the progression and challenges of the main renal fMRI methods, including dynamic contrast-enhanced MRI, blood oxygen level-dependent MRI, diffusion-weighted imaging, diffusion tensor imaging, arterial spin labeling, fat fraction imaging, and their recent clinical applications. LEVEL OF EVIDENCE 5 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;48:863-881.
Collapse
Affiliation(s)
- Jia-Ying Zhou
- Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
| | - Yuan-Cheng Wang
- Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
| | - Chu-Hui Zeng
- Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
| | - Sheng-Hong Ju
- Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
| |
Collapse
|
8
|
Abstract
Recent improvements in arterial spin labeled (ASL) and vastly undersampled dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) acquisitions are providing a new opportunity to explore the routine use of quantitative perfusion imaging for evaluation of a variety of abdominal diseases in clinical practice. In this review, we discuss different approaches for the acquisition and data analysis of ASL and DCE MRI techniques for quantification of tissue perfusion and present various clinical applications of these techniques in both neoplastic and non-neoplastic conditions in the abdomen.
Collapse
|